Advancing Monoclonal Antibody Manufacturing Through Integrated Process Intensification
June 24, 2026
Type: BioProcess Session
Explore the opportunities to optimize both the cell culture and downstream purification mab workflow.
Economic benefits for intensifying both the US and DS processes will be reviewed via case studies with evidence generated at GMP scale.
Are of focus will be cogm reduction, time savings per run and capex reduction for facility builds.
Speakers
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}